On Friday, Agilon Health Inc (NYSE: AGL) was -0.16% drop from the session before settling in for the closing price of $0.88. A 52-week range for AGL has been $0.71 – $6.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 3.29% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 15.21%. With a float of $304.05 million, this company’s outstanding shares have now reached $414.28 million.
In an organization with 1076 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -1.87%, operating margin of -6.44%, and the pretax margin is -5.55%.
Agilon Health Inc (AGL) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agilon Health Inc stocks. The insider ownership of Agilon Health Inc is 26.63%, while institutional ownership is 73.93%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.
Agilon Health Inc (AGL) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.28 earnings per share (EPS) during the time that was less than consensus figure (set at -0.09) by -0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.44% during the next five years compared to 3.29% growth over the previous five years of trading.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
You can see what Agilon Health Inc (AGL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.30 in one year’s time.